XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Sep. 30, 2019
Current Assets        
Cash and cash equivalents $ 2,507,404 $ 19,402 $ 5,249 $ 425,632
Account receivable (Note 3) 229,708 1,345,080 1,462,698
Share subscription receivable (Note 4) 827,710 827,710 2,100,000
Total current assets 2,737,112 2,192,192 2,295,657 2,525,632
Digital Asset (Note 5) 5,000,000
Total Assets 7,737,112 2,192,192 2,295,657 2,525,632
Current Liabilities        
Accruals and other payables (Note 6) 1,170,096 1,718,655 1,535,335 1,879,652
Loans payable (Note 7) 382,257 359,549 497,293
Total Liabilities 1,170,096 2,100,912 1,894,884 2,376,945
Stockholders’ Equity        
Preferred stock, $0.001010 par value, authorized; 50,000,000 shares, 5,000.000 shares issued and outstanding as of December 31, 2021, December 31, 2020, September 30, 2020 and 2019. 5,050
Common stock, $0.001 par value, authorized: 50,000,000 shares. Issued and outstanding: 19,554,667 shares as of December 31, 2021; 16,191,529 shares as of December 31, 2020, September 30, 2020 and 2019. 19,554 16,191 16,191 16,191
Additional paid-in capital 49,306,193 40,114,606 40,114,606 40,114,606
Accumulated deficit (43,788,360) (41,048,510) (40,661,350) (40,734,066)
Accumulated other comprehensive income 1,024,579 1,008,993 931,326 751,956
Total Shareholders’ Equity 6,567,016 91,280 400,773 148,687
Total Liabilities and Shareholders’ Equity $ 7,737,112 $ 2,192,192 $ 2,295,657 $ 2,525,632